EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of flavonoids in inhibiting triple-negative breast cancer

Shuai Wang, Kuanyu Wang, Cheng Li, Jing Chen, Xiangding Kong

Frontiers in Pharmacology · 27.08.2024 · 15

DOI: 10.3389/fphar.2024.1411059 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 27.08.2024. Verfasst von Shuai Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasing incidences of metastasis or recurrence (or both) in triple-negative breast cancer (TNBC) are a growing concern worldwide, as these events are intricately linked to higher mortality rates in patients with advanced breast cancer. Flavonoids possess several pharmaceutical advantages with multi-level, multi-target, and coordinated intervention abilities for treating TNBC, making them viable for preventing tumor growth and TNBC metastasis. This review focused on the primary mechanisms by which flavonoids from traditional Chinese medicine extracts inhibit TNBC, including apoptosis, blocking of cell cycle and movement, regulation of extracellular matrix degradation, promotion of anti-angiogenesis, inhibition of aerobic glycolysis, and improvement in tumor microenvironment. This review aims to improve the knowledge of flavonoids as a promising pharmacological intervention for patients with TNBC.

Schlagwörter

Stichwörter der Autor:innen

breast cancerflavonoidspharmacologytraditional Chinese medicinetriple-negative breast cancer

Autor:innen und Institutionen

  • Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China.
  • The Second Department of Surgery, The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, China.

Zitieren

APA

Wang, S., Wang, K., Li, C., Chen, J., & Kong, X. (2024). Role of flavonoids in inhibiting triple-negative breast cancer. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1411059

Vancouver

Wang S, Wang K, Li C, Chen J, Kong X. Role of flavonoids in inhibiting triple-negative breast cancer. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1411059

BibTeX
@article{Wang2024,
  author = {Wang, Shuai and Wang, Kuanyu and Li, Cheng and Chen, Jing and Kong, Xiangding},
  title = {Role of flavonoids in inhibiting triple-negative breast cancer},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1411059}
}
Kostenlos starten →